TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | -3 | -8 | -17 | -37 | -60 | -21 |
| P | %wins | 67 | 33 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/07 12:50 | 8/9/07 | OXGN | Oxigene Inc | DE | Health | BioPrd | Biological Products, (No Diag | Fickling Roy H | MA | D | P.m | 36 | 3.58 | 0 | 10 | 20 | 60 | D | -21 | 4 | -17 | -21 | -11 | -13 | -5 | -6 | 3 | -5 | -8 | -15 | -37 | -59 | |
8/8/07 14:04 | 8/7/07 | OXGN | Oxigene Inc | DE | Health | BioPrd | Biological Products, (No Diag | Fickling Roy H | MA | D | P | 16 | 3.60 | 0 | 5 | 10 | 50 | D | -19 | 8 | -13 | -17 | -4 | -8 | 4 | 2 | -2 | -6 | -9 | -20 | -38 | -61 | |
8/7/07 14:33 | 8/6/07 | OXGN | Oxigene Inc | DE | Health | BioPrd | Biological Products, (No Diag | Fickling Roy H | MA | D | P | 20 | 3.60 | 0 | 6 | 14 | 46 | D | -22 | 6 | -15 | -24 | -9 | -13 | -3 | -3 | 4 | 1 | -8 | -17 | -36 | -61 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |